| 000 | 06160naaaa2201561uu 4500 | ||
|---|---|---|---|
| 001 | https://directory.doabooks.org/handle/20.500.12854/45089 | ||
| 005 | 20220714193226.0 | ||
| 020 | _abooks978-3-03921-705-2 | ||
| 020 | _a9783039217052 | ||
| 020 | _a9783039217045 | ||
| 024 | 7 |
_a10.3390/books978-3-03921-705-2 _cdoi |
|
| 041 | 0 | _aEnglish | |
| 042 | _adc | ||
| 100 | 1 |
_aOjo, Omorogieva _4auth _91619023 |
|
| 245 | 1 | 0 | _aDietary Intake and Type 2 Diabetes |
| 260 |
_bMDPI - Multidisciplinary Digital Publishing Institute _c2019 |
||
| 300 | _a1 electronic resource (322 p.) | ||
| 506 | 0 |
_aOpen Access _2star _fUnrestricted online access |
|
| 520 | _aThe prevalence of diabetes is on the increase in the UK and worldwide, partly due to changes in lifestyle which predispose individuals to overweight and obesity. It is estimated that about 90% of the currently diagnosed adults have type 2 diabetes, and based on the World Health Organisation (WHO) report, about 422 million adults were living with diabetes in 2014 compared with 108 million in 1980; this condition caused about 1.5 million deaths in 2012. In the United States of America, it is estimated that about 30.3 million adults are living with diabetes, with a further 1.5 million new diabetes cases diagnosed every year, representing an increasing prevalence of this condition. Diabetes represents a major public health challenge, despite advances in technology and the pharmaceutical industry. These problems may be in the form of acute or long-term complications. Therefore, in order to attenuate the problems of diabetes, management strategies usually include lifestyle changes such as increased physical activity and dietary interventions. Studies which evaluate the role of nutrition in the management of type 2 diabetes often involve human and animal models as these approaches enable us to have a broader and more in-depth understanding of the condition. In some cases, diabetes may co-exist with other conditions, such as stroke, and these may present unique challenges with regard to nutritional interventions. This Special Issue aims to evaluate the risk factors associated with type 2 diabetes and the role of the diet in the management of people with this condition. This evidence is drawn from both human and animal studies. | ||
| 540 |
_aCreative Commons _fhttps://creativecommons.org/licenses/by-nc-nd/4.0/ _2cc _4https://creativecommons.org/licenses/by-nc-nd/4.0/ |
||
| 546 | _aEnglish | ||
| 653 | _alow-carbohydrate | ||
| 653 | _alipids | ||
| 653 | _acarbohydrate restricted diet | ||
| 653 | _aaldosterone | ||
| 653 | _ahigh fat diet | ||
| 653 | _ainterleukin-6 | ||
| 653 | _arosemary extract | ||
| 653 | _aHedychium coronarium | ||
| 653 | _aisomaltulose | ||
| 653 | _alow carbohydrate diet | ||
| 653 | _afolk medicine | ||
| 653 | _afree fatty acids (FFA) | ||
| 653 | _ahigh-density lipoprotein cholesterol | ||
| 653 | _amushroom | ||
| 653 | _aprotein and fat counting | ||
| 653 | _aincretins | ||
| 653 | _afish oil | ||
| 653 | _aalmond | ||
| 653 | _aJapanese | ||
| 653 | _avitamin D deficiency | ||
| 653 | _alow energy diet | ||
| 653 | _aAMPK | ||
| 653 | _awomen | ||
| 653 | _aglycaemic index | ||
| 653 | _aT2DM | ||
| 653 | _azinc status | ||
| 653 | _aginseng | ||
| 653 | _alongitudinal analysis | ||
| 653 | _adietary management approaches | ||
| 653 | _aglucose monitoring | ||
| 653 | _agut microbiome | ||
| 653 | _anutritional supplement | ||
| 653 | _acarbohydrate counting | ||
| 653 | _agestational diabetes | ||
| 653 | _atype 2 diabetes mellitus | ||
| 653 | _avery-low-calorie | ||
| 653 | _ainflammatory parameters | ||
| 653 | _avitamin D | ||
| 653 | _asubjective appetite | ||
| 653 | _arandomised controlled trial | ||
| 653 | _atotal body lean | ||
| 653 | _ainsulin secretion | ||
| 653 | _asystematic review | ||
| 653 | _alactic acid bacteria | ||
| 653 | _afood | ||
| 653 | _atype 2 diabetes | ||
| 653 | _afish | ||
| 653 | _azinc intake | ||
| 653 | _aglycaemic control | ||
| 653 | _adiabetes | ||
| 653 | _adairy products | ||
| 653 | _aglycated haemoglobin | ||
| 653 | _ashort chain fatty acids | ||
| 653 | _aglycated hemoglobin A | ||
| 653 | _aglycemic control | ||
| 653 | _avegetable oil | ||
| 653 | _astandard formula | ||
| 653 | _acardiovascular risk factors | ||
| 653 | _aDASH | ||
| 653 | _ainsulin dosage | ||
| 653 | _aappendicular fat | ||
| 653 | _abody composition | ||
| 653 | _atotal body fat | ||
| 653 | _amicronutrients | ||
| 653 | _a25-OH-D | ||
| 653 | _aobesity | ||
| 653 | _adiabetes reversal | ||
| 653 | _aenteral nutrition | ||
| 653 | _aPUFA | ||
| 653 | _abody mass index | ||
| 653 | _ametabolic syndrome | ||
| 653 | _alifestyle management | ||
| 653 | _anutrition | ||
| 653 | _astreptozotocin | ||
| 653 | _anuts | ||
| 653 | _aenteral tube feeding | ||
| 653 | _alipid profile | ||
| 653 | _amacronutrients | ||
| 653 | _atriglyceride | ||
| 653 | _atempeh | ||
| 653 | _acohort study | ||
| 653 | _adiabetes specific formula | ||
| 653 | _apolyunsaturated fatty acids | ||
| 653 | _adiabetes mellitus | ||
| 653 | _acalcium intake | ||
| 653 | _ahyperglycemia | ||
| 653 | _aepidemiology | ||
| 653 | _atrace elements | ||
| 653 | _adietary intake | ||
| 653 | _amuscle | ||
| 653 | _aappendicular lean | ||
| 653 | _apeanut | ||
| 653 | _ainsulin resistance | ||
| 653 | _asucromalt | ||
| 653 | _apancreatectomy | ||
| 653 | _aenergy restricted diet | ||
| 653 | _aglycemic index | ||
| 653 | _atype 1 diabetes | ||
| 653 | _afasting blood glucose | ||
| 653 | _abariatric surgery | ||
| 653 | _aprediabetes | ||
| 653 | _aaronia | ||
| 653 | _ameta-analysis | ||
| 653 | _achronic conditions | ||
| 653 | _adiabetes management | ||
| 653 | _adietary pattern | ||
| 653 | _adiet quality | ||
| 653 | _alipid parameters | ||
| 653 | _afeces | ||
| 856 | 4 | 0 |
_awww.oapen.org _uhttps://mdpi.com/books/pdfview/book/1871 _70 _zDOAB: download the publication |
| 856 | 4 | 0 |
_awww.oapen.org _uhttps://directory.doabooks.org/handle/20.500.12854/45089 _70 _zDOAB: description of the publication |
| 999 |
_c3017700 _d3017700 |
||